| Symbol | ADTX |
|---|---|
| Name | ADITXT, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 2569 WYANDOTTE STREET,SUITE 101, MOUNTAIN VIEW, California, 94043, United States |
| Telephone | +1 650 - 870-1200 |
| Fax | — |
| — | |
| Website | https://www.aditxt.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firms immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the bodys natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues. Additional info from NASDAQ: |
New Form EFFECT - Aditxt, Inc. <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 9999999995-26-001275 <b>Size:</b> 1 KB
Read moreDana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients
Read moreNew Form 8-K/A - Aditxt, Inc. <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001213900-26-041018 <b>Size:</b> 783 KB <br />Item 9.01: Financial Statements and Exhibits
Read moreNew Form DEF 14A - Aditxt, Inc. <b>Filed:</b> 2026-04-03 <b>AccNo:</b> 0001213900-26-039987 <b>Size:</b> 335 KB
Read moreNASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.
Read moreNASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.
Read moreNew Form 10-K - Aditxt, Inc. <b>Filed:</b> 2026-03-31 <b>AccNo:</b> 0001213900-26-037529 <b>Size:</b> 11 MB
Read more